121 related articles for article (PubMed ID: 6428895)
1. The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcoma.
Langdon SP; Gescher A; Hickman JA; Stevens MF
Eur J Cancer Clin Oncol; 1984 May; 20(5):699-705. PubMed ID: 6428895
[TBL] [Abstract][Full Text] [Related]
2. N-methylformamide: antitumour activity and metabolism in mice.
Gescher A; Gibson NW; Hickman JA; Langdon SP; Ross D; Atassi G
Br J Cancer; 1982 Jun; 45(6):843-50. PubMed ID: 7201320
[TBL] [Abstract][Full Text] [Related]
3. The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051).
Cooksey PG; Gate EN; Gescher A; Hickman JA; Langdon SP; Stevens MF
Biochem Pharmacol; 1983 Oct; 32(20):3037-43. PubMed ID: 6639672
[TBL] [Abstract][Full Text] [Related]
4. Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility.
Cumber AJ; Ross WC
Chem Biol Interact; 1977 Jun; 17(3):349-57. PubMed ID: 407012
[TBL] [Abstract][Full Text] [Related]
5. Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolism.
Ross D; Langdon SP; Gescher A; Stevens MF
Biochem Pharmacol; 1984 Apr; 33(7):1131-6. PubMed ID: 6424683
[TBL] [Abstract][Full Text] [Related]
6. N-methyl antitumour agents. A distinct class of anticancer drugs?
Newell D; Gescher A; Harland S; Ross D; Rutty C
Cancer Chemother Pharmacol; 1987; 19(2):91-102. PubMed ID: 3552281
[TBL] [Abstract][Full Text] [Related]
7. Studies on the toxicity of the antitumour agent N-methylformamide in mice.
Langdon SP; Chubb D; Gescher A; Hickman JA; Stevens MF
Toxicology; 1985 Feb; 34(2):173-83. PubMed ID: 3969688
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2,2'-O-cyclocytidine on transplanted lymphocytic sarcoma and reticulum cell sarcoma in mice.
Nakahara W; Tokuzen R
Gan; 1972 Jun; 63(3):379-81. PubMed ID: 4561278
[No Abstract] [Full Text] [Related]
9. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362.
Xie K; Huang S; Dong Z; Gutman M; Fidler IJ
Cancer Res; 1995 Jul; 55(14):3123-31. PubMed ID: 7541713
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel mouse reticular cell sarcoma M5076 subline resistant to cisplatin.
Ferrari A; Damia G; Erba E; Rossi C; Mandelli R; D'Incalci M
Int J Cancer; 1989 Jun; 43(6):1091-7. PubMed ID: 2659542
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma.
Lowenbraun S; DeVita VT; Serpick AA
Cancer; 1970 May; 25(5):1018-25. PubMed ID: 4910254
[No Abstract] [Full Text] [Related]
13. Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin.
Talmadge JE; Key ME; Hart IR
Cancer Res; 1981 Apr; 41(4):1271-80. PubMed ID: 7011532
[TBL] [Abstract][Full Text] [Related]
14. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H
Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048
[TBL] [Abstract][Full Text] [Related]
15. Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
Broggini M; Rossi C; Colombo T; D'Incalci M
Cancer Treat Rep; 1982 Jan; 66(1):127-33. PubMed ID: 6796267
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of hexamethylmelamine on human tumor xenografts serially transplanted in nude mice.
Kubota T; Tanino H; Watanabe M; Kitajima M
Anticancer Res; 1994; 14(6B):2521-4. PubMed ID: 7872676
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin.
Belvedere G; Imperatori L; Damia G; Tagliabue G; Meijer C; de Vries EG; D'Incalci M
Eur J Cancer; 1996 Oct; 32A(11):2011-8. PubMed ID: 8943689
[TBL] [Abstract][Full Text] [Related]
19. Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamide.
Gate EN; Threadgill MD; Stevens MF; Chubb D; Vickers LM; Langdon SP; Hickman JA; Gescher A
J Med Chem; 1986 Jun; 29(6):1046-52. PubMed ID: 3712373
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
Perez-Soler R; Khokhar AR; Lopez-Berestein G
Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
